Deitelzweig S - Search Results

1

All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants.

Deitelzweig S, Luo X, Gupta K, Trocio J, Mardekian J, Curtice T, Hlavacek P, Lingohr-Smith M, Menges B, Lin J. Deitelzweig S, et al. Clin Appl Thromb Hemost. 2018 May;24(4):602-611. doi: 10.1177/1076029617750269. Epub 2018 Jan 24. Clin Appl Thromb Hemost. 2018. PMID: 29363999 Free PMC article.

2

Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism.

Deitelzweig SB, Becker R, Lin J, Benner J. Deitelzweig SB, et al. Thromb Haemost. 2008 Nov;100(5):810-20. Thromb Haemost. 2008. PMID: 18989525

3

Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis?

Deitelzweig SB, Lin J, Hussein M, Battleman D. Deitelzweig SB, et al. J Thromb Thrombolysis. 2010 Jul;30(1):55-66. doi: 10.1007/s11239-009-0393-4. J Thromb Thrombolysis. 2010. PMID: 19795190

4

Venous thromboembolism in the US: does race matter?

Deitelzweig SB, Lin J, Johnson BH, Schulman KL. Deitelzweig SB, et al. J Thromb Thrombolysis. 2011 Feb;31(2):133-8. doi: 10.1007/s11239-010-0503-3. J Thromb Thrombolysis. 2011. PMID: 20658176

5

Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes.

Deitelzweig SB, Lin J, Kreilick C, Hussein M, Battleman D. Deitelzweig SB, et al. Adv Ther. 2010 Sep;27(9):623-33. doi: 10.1007/s12325-010-0056-z. Epub 2010 Jul 30. Adv Ther. 2010. PMID: 20680533

6

Prevalence of clinical venous thromboembolism in the USA: current trends and future projections.

Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Deitelzweig SB, et al. Am J Hematol. 2011 Feb;86(2):217-20. doi: 10.1002/ajh.21917. Am J Hematol. 2011. PMID: 21264912 Free article.

7

Preventing venous thromboembolism following orthopedic surgery in the United States: impact of special populations on clinical outcomes.

Deitelzweig SB, Lin J, Lin G. Deitelzweig SB, et al. Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):640-50. doi: 10.1177/1076029611404215. Epub 2011 May 17. Clin Appl Thromb Hemost. 2011. PMID: 21593017 Free article.

8

Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials.

Deitelzweig S, Amin A, Jing Y, Makenbaeva D, Wiederkehr D, Lin J, Graham J. Deitelzweig S, et al. J Med Econ. 2012;15(4):776-85. doi: 10.3111/13696998.2012.680555. Epub 2012 Apr 13. J Med Econ. 2012. PMID: 22449118 Free article.

9

Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis.

Deitelzweig S, Amin A, Christian R, Friend K, Lin J, Lowe TJ. Deitelzweig S, et al. Adv Ther. 2013 Jan;30(1):71-80. doi: 10.1007/s12325-012-0073-1. Epub 2012 Dec 21. Adv Ther. 2013. PMID: 23292659

10

Transitions of care in anticoagulation management for patients with atrial fibrillation.

Deitelzweig SB. Deitelzweig SB. Hosp Pract (1995). 2012 Oct;40(4):20-7. doi: 10.3810/hp.2012.10.999. Hosp Pract (1995). 2012. PMID: 23299032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters